The suitability of [18F]CFT as a radioligand for in vivo studies of DAT in humans has been evaluated [9], and [18F]CFT has been used in human studies of Parkinson's disease [10-15], schizophrenia [16,17], and detached personality [18]. Here, SLC6A3 is linked to Parkinson disease.